Genetic Departement, rare disease, personalized medicine
Montpellier, Herault, 34295, France
NCT Number: NCT03547609
Mnesic function has not, at present, been evaluated in patients with Kabuki Syndrome. Some data from the neuroimagery suggest an impairment of memory function. The objective of our study is to assess the mnesic function of children with Kabuki Syndrom.
Looking for future studies?
Notify Me6 year–16 year
All sexes
Interventional
Not applicable
Montpellier, Herault, 34295, France
Kabuki Syndrome (SK - OMIM 147920 and 300867 ORPHA: 2322) is a rare genetic disease with a prevalence of approximately 1/32 000 and responsible for a malformation syndrome with mild to moderate intellectual impairment. SK is due to mutations in the KMT2D and KDM6A genes. As part of a national PHRC (AOM 07-090, clinicaltrial NCT01314534, The investigators were able to perform psychometric tests type WISC4 and MRI type VBM). Disability in SK is characterized by a heterogeneous cognitive profile with strengths and weaknesses when calculating IQ. Brain MRI reveals small hippocampi compared to controls. These 2 data are partly contradictory because the strengths of the patients with SK are a working memory and a verbal comprehension index high compared to the other indices of the tests WISC-IV.
The objective of the research is to better understand the mnesic function of children with SK.
25 children aged 6 to 16 will be recruited. The diagnosis of SK will have been authenticated by the demonstration of a mutation in the KMT2D or KDM6A gene.
The memory assessments will be conducted in one visit for each child, who will perform a memory assessment with a neuropsychologist, using the CMS scale.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No arm intervention
Time frame: 1 hour
CMS main score
Time frame: 1 hour
CMS indexes
University Hospital, Montpellier
Other
Study on the Mnemic Functioning of Children With Kabuki Syndrome
Acronym: MEM-K
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04722315
Kabuki Syndrome, Kabuki syndrome
Baltimore, Maryland, United States
View Trial DetailsNCT01314534
Kabuki Syndrome, Kabuki syndrome
Paris, France
View Trial DetailsNCT01793168
1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V
Sioux Falls, South Dakota, United States
View Trial DetailsNCT03855631
Kabuki Syndrome 1, Kabuki syndrome
Montpellier, Herault, France
View Trial Details